{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:10:16Z","timestamp":1795043416386,"version":"4.10.2"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liver steatosis, inflammation, and variable degrees of fibrosis are the pathological manifestations of nonalcoholic steatohepatitis (NASH), an aggressive presentation of the most prevalent chronic liver disease in the Western world known as nonalcoholic fatty liver (NAFL). Mitochondrial hepatocyte dysfunction is a primary event that triggers inflammation, affecting Kupffer and hepatic stellate cell behaviour. Here, we consider the role of impaired mitochondrial function caused by lipotoxicity during oxidative stress in hepatocytes. Dysfunction in oxidative phosphorylation and mitochondrial ROS production cause the release of damage-associated molecular patterns from dying hepatocytes, leading to activation of innate immunity and trans-differentiation of hepatic stellate cells, thereby driving fibrosis in NASH.<\/jats:p>","DOI":"10.1186\/s12967-023-04627-0","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T12:02:13Z","timestamp":1698321733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions"],"prefix":"10.1186","volume":"21","author":[{"given":"Melissa","family":"Myint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Oppedisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"De Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Moo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco M.","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey J.","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8569-7158","authenticated-orcid":false,"given":"Salvatore","family":"Nesci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"4627_CR1","first-page":"14","volume":"22","author":"C Zhang","year":"2021","unstructured":"Zhang C, Yang M. Current options and future directions for NAFLD and NASH treatment. Int J Mol Sci. 2021;22:14.","journal-title":"Int J Mol Sci"},{"key":"4627_CR2","first-page":"75","volume":"8","author":"BA Banini","year":"2016","unstructured":"Banini BA, Sanyal AJ. Nonalcoholic fatty liver disease: epidemiology, pathogenesis, natural history, diagnosis, and current treatment options. Clin Med Insights Ther. 2016;8:75\u201384.","journal-title":"Clin Med Insights Ther"},{"issue":"4","key":"4627_CR3","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI96139","volume":"128","author":"M Shimobayashi","year":"2018","unstructured":"Shimobayashi M, Albert V, Woelnerhanssen B, Frei IC, Weissenberger D, Meyer-Gerspach AC, et al. Insulin resistance causes inflammation in adipose tissue. J Clin Invest. 2018;128(4):1538\u201350.","journal-title":"J Clin Invest"},{"issue":"1","key":"4627_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clnu.2017.01.006","volume":"37","author":"GS de Castro","year":"2018","unstructured":"de Castro GS, Calder PC. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clin Nutr. 2018;37(1):37\u201355.","journal-title":"Clin Nutr"},{"issue":"4","key":"4627_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/febs.14209","volume":"285","author":"C Ma","year":"2018","unstructured":"Ma C, Zhang Q, Greten TF. Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes. FEBS J. 2018;285(4):752\u201362.","journal-title":"FEBS J"},{"issue":"23","key":"4627_CR6","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.3748\/wjg.v23.i23.4146","volume":"23","author":"A Ferramosca","year":"2017","unstructured":"Ferramosca A, Di Giacomo M, Zara V. Antioxidant dietary approach in treatment of fatty liver: new insights and updates. World J Gastroenterol. 2017;23(23):4146\u201357.","journal-title":"World J Gastroenterol"},{"key":"4627_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pharmthera.2017.07.007","volume":"181","author":"DB Jump","year":"2018","unstructured":"Jump DB, Lytle KA, Depner CM, Tripathy S. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacol Ther. 2018;181:108\u201325.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"4627_CR8","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/nu12051435","volume":"12","author":"F Oppedisano","year":"2020","unstructured":"Oppedisano F, Muscoli C, Musolino V, Carresi C, Macri R, Giancotta C, et al. The Protective effect of cynara cardunculus extract in diet-induced NAFLD: involvement of OCTN1 and OCTN2 transporter subfamily. Nutrients. 2020;12(5):1435.","journal-title":"Nutrients"},{"key":"4627_CR9","first-page":"147","volume":"7","author":"SM Kessler","year":"2016","unstructured":"Kessler SM, Laggai S, Van Wonterg E, Gemperlein K, Muller R, Haybaeck J, et al. Transient hepatic overexpression of insulin-like growth factor 2 induces free cholesterol and lipid droplet formation. Front Physiol. 2016;7:147.","journal-title":"Front Physiol"},{"issue":"12","key":"4627_CR10","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3390\/biom10121702","volume":"10","author":"C Rives","year":"2020","unstructured":"Rives C, Fougerat A, Ellero-Simatos S, Loiseau N, Guillou H, Gamet-Payrastre L, et al. Oxidative stress in NAFLD: role of nutrients and food contaminants. Biomolecules. 2020;10(12):1702.","journal-title":"Biomolecules"},{"issue":"7","key":"4627_CR11","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3390\/ijms18071534","volume":"18","author":"P Dongiovanni","year":"2017","unstructured":"Dongiovanni P, Valenti L. A nutrigenomic approach to non-alcoholic fatty liver disease. Int J Mol Sci. 2017;18(7):1534.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4627_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809302","volume":"11","author":"AA Kolodziejczyk","year":"2019","unstructured":"Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E. The role of the microbiome in NAFLD and NASH. EMBO Mol Med. 2019;11(2): e9302.","journal-title":"EMBO Mol Med"},{"issue":"8","key":"4627_CR13","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/ijms18081649","volume":"18","author":"TE Adolph","year":"2017","unstructured":"Adolph TE, Grander C, Grabherr F, Tilg H. Adipokines and non-alcoholic fatty liver disease: multiple interactions. Int J Mol Sci. 2017;18(8):1649.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4627_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/endrev\/bnad005","volume":"44","author":"V Vella","year":"2023","unstructured":"Vella V, Lappano R, Bonavita E, Maggiolini M, Clarke RB, Belfiore A, et al. Insulin\/IGF axis and the receptor for advanced glycation end products: role in meta-inflammation and potential in cancer therapy. Endocr Rev. 2023;44(4):693\u2013723.","journal-title":"Endocr Rev"},{"issue":"20","key":"4627_CR15","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.3390\/ijms20205037","volume":"20","author":"DH Fernando","year":"2019","unstructured":"Fernando DH, Forbes JM, Angus PW, Herath CB. Development and progression of non-alcoholic fatty liver disease: the role of advanced glycation end products. Int J Mol Sci. 2019;20(20):5037.","journal-title":"Int J Mol Sci"},{"key":"4627_CR16","doi-asserted-by":"publisher","first-page":"2151302","DOI":"10.1155\/2019\/2151302","volume":"2019","author":"K Asadipooya","year":"2019","unstructured":"Asadipooya K, Lankarani KB, Raj R, Kalantarhormozi M. RAGE is a potential cause of onset and progression of nonalcoholic fatty liver disease. Int J Endocrinol. 2019;2019:2151302.","journal-title":"Int J Endocrinol"},{"issue":"3","key":"4627_CR17","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.26717","volume":"59","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014;59(3):1174\u201397.","journal-title":"Hepatology"},{"issue":"2","key":"4627_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S2468-1253(16)30018-8","volume":"1","author":"E Degasperi","year":"2016","unstructured":"Degasperi E, Colombo M. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol. 2016;1(2):156\u201364.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4627_CR19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ejphar.2016.09.037","volume":"791","author":"A Silva","year":"2016","unstructured":"Silva A, Gomes F, Santos Silva BD, Ribeiro EL, Oliveira AC, Araujo S, et al. Chronic LPSF\/GQ-02 treatment attenuates inflammation and atherosclerosis development in LDLr(-\/-) mice. Eur J Pharmacol. 2016;791:622\u201331.","journal-title":"Eur J Pharmacol"},{"issue":"74","key":"4627_CR20","doi-asserted-by":"publisher","first-page":"eabl3795","DOI":"10.1126\/sciimmunol.abl3795","volume":"7","author":"CC Clement","year":"2022","unstructured":"Clement CC, Osan J, Buque A, Nanaware PP, Chang YC, Perino G, et al. PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes. Sci Immunol. 2022;7(74):eabl3795.","journal-title":"Sci Immunol"},{"issue":"3","key":"4627_CR21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909\u201350.","journal-title":"Physiol Rev"},{"key":"4627_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biocel.2017.12.019","volume":"95","author":"ICM Simoes","year":"2018","unstructured":"Simoes ICM, Fontes A, Pinton P, Zischka H, Wieckowski MR. Mitochondria in non-alcoholic fatty liver disease. Int J Biochem Cell Biol. 2018;95:93\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"18","key":"4627_CR23","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313\u201327.","journal-title":"Cell Mol Life Sci"},{"issue":"18","key":"4627_CR24","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/CS20220572","volume":"136","author":"OO Badmus","year":"2022","unstructured":"Badmus OO, Hillhouse SA, Anderson CD, Hinds TD, Stec DE. Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways. Clin Sci (Lond). 2022;136(18):1347\u201366.","journal-title":"Clin Sci (Lond)"},{"issue":"9","key":"4627_CR25","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1074\/jbc.M807616200","volume":"284","author":"ZZ Li","year":"2009","unstructured":"Li ZZ, Berk M, McIntyre TM, Feldstein AE. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem. 2009;284(9):5637\u201344.","journal-title":"J Biol Chem"},{"issue":"4","key":"4627_CR26","first-page":"671","volume":"34","author":"GW Power","year":"1994","unstructured":"Power GW, Yaqoob P, Harvey DJ, Newsholme EA, Calder PC. The effect of dietary lipid manipulation on hepatic mitochondrial phospholipid fatty acid composition and carnitine palmitoyltransferase I activity. Biochem Mol Biol Int. 1994;34(4):671\u201384.","journal-title":"Biochem Mol Biol Int"},{"issue":"4","key":"4627_CR27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ceb.2013.03.005","volume":"25","author":"C Klose","year":"2013","unstructured":"Klose C, Surma MA, Simons K. Organellar lipidomics\u2013background and perspectives. Curr Opin Cell Biol. 2013;25(4):406\u201313.","journal-title":"Curr Opin Cell Biol"},{"key":"4627_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101134","volume":"50","author":"M Shum","year":"2021","unstructured":"Shum M, Ngo J, Shirihai OS, Liesa M. Mitochondrial oxidative function in NAFLD: friend or foe? Mol Metab. 2021;50: 101134.","journal-title":"Mol Metab"},{"issue":"12","key":"4627_CR29","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/nm.3735","volume":"20","author":"AP Arruda","year":"2014","unstructured":"Arruda AP, Pers BM, Parlakgul G, Guney E, Inouye K, Hotamisligil GS. Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat Med. 2014;20(12):1427\u201335.","journal-title":"Nat Med"},{"issue":"7828","key":"4627_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41586-020-2551-y","volume":"586","author":"P Hernansanz-Agustin","year":"2020","unstructured":"Hernansanz-Agustin P, Choya-Foces C, Carregal-Romero S, Ramos E, Oliva T, Villa-Pina T, et al. Na(+) controls hypoxic signalling by the mitochondrial respiratory chain. Nature. 2020;586(7828):287\u201391.","journal-title":"Nature"},{"issue":"3","key":"4627_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2023.148977","volume":"1864","author":"S Nesci","year":"2023","unstructured":"Nesci S, Algieri C, Trombetti F, Fabbri M, Lenaz G. Two separate pathways underlie NADH and succinate oxidation in swine heart mitochondria: Kinetic evidence on the mobile electron carriers. Biochim Biophys Acta Bioenerg. 2023;1864(3): 148977.","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"5","key":"4627_CR32","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.3390\/ijms15058713","volume":"15","author":"F Nassir","year":"2014","unstructured":"Nassir F, Ibdah JA. Role of mitochondria in nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(5):8713\u201342.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4627_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","volume":"92","author":"P Nguyen","year":"2008","unstructured":"Nguyen P, Leray V, Diez M, Serisier S, Le Bloc\u2019h J, Siliart B, et al. Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl). 2008;92(3):272\u201383.","journal-title":"J Anim Physiol Anim Nutr (Berl)"},{"key":"4627_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","volume":"11","author":"T Hardy","year":"2016","unstructured":"Hardy T, Oakley F, Anstee QM, Day CP. Nonalcoholic fatty liver disease: pathogenesis and disease spectrum. Annu Rev Pathol. 2016;11:451\u201396.","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"4627_CR35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cmet.2019.02.011","volume":"29","author":"IY Benador","year":"2019","unstructured":"Benador IY, Veliova M, Liesa M, Shirihai OS. Mitochondria bound to lipid droplets: where mitochondrial dynamics regulate lipid storage and utilization. Cell Metab. 2019;29(4):827\u201335.","journal-title":"Cell Metab"},{"issue":"10 Pt B","key":"4627_CR36","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.bbalip.2017.06.005","volume":"1862","author":"M Schuldiner","year":"2017","unstructured":"Schuldiner M, Bohnert M. A different kind of love\u2014lipid droplet contact sites. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(10 Pt B):1188\u201396.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"4627_CR37","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41467-023-36432-0","volume":"14","author":"NK Talari","year":"2023","unstructured":"Talari NK, Mattam U, Meher NK, Paripati AK, Mahadev K, Krishnamoorthy T, et al. Lipid-droplet associated mitochondria promote fatty-acid oxidation through a distinct bioenergetic pattern in male Wistar rats. Nat Commun. 2023;14(1):766.","journal-title":"Nat Commun"},{"issue":"3","key":"4627_CR38","first-page":"242","volume":"11","author":"S Nesci","year":"2021","unstructured":"Nesci S, Trombetti F, Pagliarani A, Ventrella V, Algieri C, Tioli G, et al. Molecular and supramolecular structure of the mitochondrial oxidative phosphorylation system: implications for pathology. Life (Basel). 2021;11(3):242.","journal-title":"Life (Basel)"},{"key":"4627_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0065-2571(68)90005-8","volume":"6","author":"PB Garland","year":"1968","unstructured":"Garland PB, Shepherd D, Nicholls DG, Ontko J. Energy-dependent control of the tricarboxylic acid cycle by fatty acid oxidation in rat liver mitochondria. Adv Enzyme Regul. 1968;6:3\u201330.","journal-title":"Adv Enzyme Regul"},{"issue":"5","key":"4627_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmet.2010.10.001","volume":"12","author":"M Beller","year":"2010","unstructured":"Beller M, Bulankina AV, Hsiao HH, Urlaub H, Jackle H, Kuhnlein RP. PERILIPIN-dependent control of lipid droplet structure and fat storage in Drosophila. Cell Metab. 2010;12(5):521\u201332.","journal-title":"Cell Metab"},{"issue":"12","key":"4627_CR41","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1194\/jlr.M017939","volume":"52","author":"H Wang","year":"2011","unstructured":"Wang H, Sreenivasan U, Hu H, Saladino A, Polster BM, Lund LM, et al. Perilipin 5, a lipid droplet-associated protein, provides physical and metabolic linkage to mitochondria. J Lipid Res. 2011;52(12):2159\u201368.","journal-title":"J Lipid Res"},{"issue":"10","key":"4627_CR42","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/cells8101241","volume":"8","author":"Y Tan","year":"2019","unstructured":"Tan Y, Jin Y, Wang Q, Huang J, Wu X, Ren Z. Perilipin 5 protects against cellular oxidative stress by enhancing mitochondrial function in HepG2 cells. Cells. 2019;8(10):1241.","journal-title":"Cells"},{"issue":"3","key":"4627_CR43","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/hep.27409","volume":"61","author":"C Wang","year":"2015","unstructured":"Wang C, Zhao Y, Gao X, Li L, Yuan Y, Liu F, et al. Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis. Hepatology. 2015;61(3):870\u201382.","journal-title":"Hepatology"},{"key":"4627_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.semcdb.2020.04.013","volume":"108","author":"M Veliova","year":"2020","unstructured":"Veliova M, Petcherski A, Liesa M, Shirihai OS. The biology of lipid droplet-bound mitochondria. Semin Cell Dev Biol. 2020;108:55\u201364.","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"4627_CR45","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.tcb.2016.04.006","volume":"26","author":"V Izzo","year":"2016","unstructured":"Izzo V, Bravo-San Pedro JM, Sica V, Kroemer G, Galluzzi L. Mitochondrial permeability transition: new findings and persisting uncertainties. Trends Cell Biol. 2016;26(9):655\u201367.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"4627_CR46","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/hep.27420","volume":"61","author":"L Wang","year":"2015","unstructured":"Wang L, Liu X, Nie J, Zhang J, Kimball SR, Zhang H, et al. ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology. 2015;61(2):486\u201396.","journal-title":"Hepatology"},{"key":"4627_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101051","volume":"41","author":"LR Edmunds","year":"2020","unstructured":"Edmunds LR, Xie B, Mills AM, Huckestein BR, Undamatla R, Murali A, et al. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance. Mol Metab. 2020;41: 101051.","journal-title":"Mol Metab"},{"issue":"1","key":"4627_CR48","doi-asserted-by":"publisher","first-page":"7575","DOI":"10.1038\/s41598-023-34710-x","volume":"13","author":"R Undamatla","year":"2023","unstructured":"Undamatla R, Fagunloye OG, Chen J, Edmunds LR, Murali A, Mills A, et al. Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis. Sci Rep. 2023;13(1):7575.","journal-title":"Sci Rep"},{"issue":"5","key":"4627_CR49","doi-asserted-by":"publisher","first-page":"G324","DOI":"10.1152\/ajpgi.00108.2015","volume":"309","author":"JA Williams","year":"2015","unstructured":"Williams JA, Ni HM, Ding Y, Ding WX. Parkin regulates mitophagy and mitochondrial function to protect against alcohol-induced liver injury and steatosis in mice. Am J Physiol Gastrointest Liver Physiol. 2015;309(5):G324\u201340.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"4627_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcb.2019.11.001","volume":"30","author":"S Nesci","year":"2020","unstructured":"Nesci S, Trombetti F, Pagliarani A. Nicotinamide nucleotide transhydrogenase as a sensor of mitochondrial biology. Trends Cell Biol. 2020;30(1):1\u20133.","journal-title":"Trends Cell Biol"},{"key":"4627_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.freeradbiomed.2017.09.026","volume":"113","author":"CDC Navarro","year":"2017","unstructured":"Navarro CDC, Figueira TR, Francisco A, Dal\u2019Bo GA, Ronchi JA, Rovani JC, et al. Redox imbalance due to the loss of mitochondrial NAD(P)-transhydrogenase markedly aggravates high fat diet-induced fatty liver disease in mice. Free Radic Biol Med. 2017;113:190\u2013202.","journal-title":"Free Radic Biol Med"},{"issue":"2\u20133","key":"4627_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0014-5793(94)00370-X","volume":"344","author":"LA Sazanov","year":"1994","unstructured":"Sazanov LA, Jackson JB. Proton-translocating transhydrogenase and NAD- and NADP-linked isocitrate dehydrogenases operate in a substrate cycle which contributes to fine regulation of the tricarboxylic acid cycle activity in mitochondria. FEBS Lett. 1994;344(2\u20133):109\u201316.","journal-title":"FEBS Lett"},{"issue":"5","key":"4627_CR53","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.cell.2010.10.002","volume":"143","author":"S Someya","year":"2010","unstructured":"Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell. 2010;143(5):802\u201312.","journal-title":"Cell"},{"issue":"10","key":"4627_CR54","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1128\/MCB.01658-12","volume":"33","author":"J He","year":"2013","unstructured":"He J, Hu B, Shi X, Weidert ER, Lu P, Xu M, et al. Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3. Mol Cell Biol. 2013;33(10):2047\u201355.","journal-title":"Mol Cell Biol"},{"key":"4627_CR55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2022.07.018","volume":"190","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhao Y, Wang S, Li G, Xu K. CREBH alleviates mitochondrial oxidative stress through SIRT3 mediating deacetylation of MnSOD and suppression of Nlrp3 inflammasome in NASH. Free Radic Biol Med. 2022;190:28\u201341.","journal-title":"Free Radic Biol Med"},{"issue":"7640","key":"4627_CR56","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385.","journal-title":"Nature"},{"issue":"3","key":"4627_CR57","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","volume":"90","author":"H Malhi","year":"2010","unstructured":"Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev. 2010;90(3):1165\u201394.","journal-title":"Physiol Rev"},{"issue":"5","key":"4627_CR58","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jhep.2016.07.002","volume":"65","author":"A Wree","year":"2016","unstructured":"Wree A, Marra F. The inflammasome in liver disease. J Hepatol. 2016;65(5):1055\u20136.","journal-title":"J Hepatol"},{"issue":"3","key":"4627_CR59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L. Mitochondrial control of inflammation. Nat Rev Immunol. 2023;23(3):159\u201373.","journal-title":"Nat Rev Immunol"},{"key":"4627_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-biochem-032620-104401","volume":"92","author":"LE Newman","year":"2023","unstructured":"Newman LE, Shadel GS. Mitochondrial DNA release in innate immune signaling. Annu Rev Biochem. 2023;92:299\u2013332.","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"4627_CR61","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949799","volume":"21","author":"JS Riley","year":"2020","unstructured":"Riley JS, Tait SW. Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020;21(4): e49799.","journal-title":"EMBO Rep"},{"issue":"7850","key":"4627_CR62","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-021-03269-w","volume":"591","author":"M Tigano","year":"2021","unstructured":"Tigano M, Vargas DC, Tremblay-Belzile S, Fu Y, Sfeir A. Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance. Nature. 2021;591(7850):477\u201381.","journal-title":"Nature"},{"issue":"5806","key":"4627_CR63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/290457a0","volume":"290","author":"S Anderson","year":"1981","unstructured":"Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290(5806):457\u201365.","journal-title":"Nature"},{"key":"4627_CR64","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev.genet.33.1.351","volume":"33","author":"BF Lang","year":"1999","unstructured":"Lang BF, Gray MW, Burger G. Mitochondrial genome evolution and the origin of eukaryotes. Annu Rev Genet. 1999;33:351\u201397.","journal-title":"Annu Rev Genet"},{"issue":"1","key":"4627_CR65","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0021-9258(18)48474-8","volume":"267","author":"KC Cheng","year":"1992","unstructured":"Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem. 1992;267(1):166\u201372.","journal-title":"J Biol Chem"},{"issue":"13","key":"4627_CR66","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1158\/0008-5472.CAN-04-0355","volume":"64","author":"MT Russo","year":"2004","unstructured":"Russo MT, De Luca G, Degan P, Parlanti E, Dogliotti E, Barnes DE, et al. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases. Cancer Res. 2004;64(13):4411\u20134.","journal-title":"Cancer Res"},{"issue":"7","key":"4627_CR67","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.3390\/ijms24076106","volume":"24","author":"S Nesci","year":"2023","unstructured":"Nesci S, Spagnoletta A, Oppedisano F. Inflammation, mitochondria and natural compounds together in the circle of trust. Int J Mol Sci. 2023;24(7):6106.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4627_CR68","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/med.21635","volume":"40","author":"S Nesci","year":"2020","unstructured":"Nesci S. The mitochondrial permeability transition pore in cell death: a promising drug binding bioarchitecture. Med Res Rev. 2020;40(2):811\u20137.","journal-title":"Med Res Rev"},{"issue":"8","key":"4627_CR69","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","volume":"55","author":"H Xian","year":"2022","unstructured":"Xian H, Watari K, Sanchez-Lopez E, Offenberger J, Onyuru J, Sampath H, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55(8):1370-85 e8.","journal-title":"Immunity"},{"issue":"5","key":"4627_CR70","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik S, Kim JK, Silwal P, Sasakawa C, Jo EK. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. 2021;18(5):1141\u201360.","journal-title":"Cell Mol Immunol"},{"key":"4627_CR71","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1146\/annurev-biochem-040320-101629","volume":"91","author":"C Ritchie","year":"2022","unstructured":"Ritchie C, Carozza JA, Li L. Biochemistry, cell biology, and pathophysiology of the innate immune cGAS-cGAMP-STING pathway. Annu Rev Biochem. 2022;91:599\u2013628.","journal-title":"Annu Rev Biochem"},{"issue":"7549","key":"4627_CR72","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nature14138","volume":"520","author":"U Ohto","year":"2015","unstructured":"Ohto U, Shibata T, Tanji H, Ishida H, Krayukhina E, Uchiyama S, et al. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature. 2015;520(7549):702\u20135.","journal-title":"Nature"},{"issue":"11","key":"4627_CR73","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.3390\/cells10112898","volume":"10","author":"A De Gaetano","year":"2021","unstructured":"De Gaetano A, Solodka K, Zanini G, Selleri V, Mattioli AV, Nasi M, et al. Molecular mechanisms of mtDNA-mediated inflammation. Cells. 2021;10(11):2898.","journal-title":"Cells"},{"issue":"1","key":"4627_CR74","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010;139(1):323-34 e7.","journal-title":"Gastroenterology"},{"issue":"5","key":"4627_CR75","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2015.12.057","volume":"164","author":"Z Zhong","year":"2016","unstructured":"Zhong Z, Umemura A, Sanchez-Lopez E, Liang S, Shalapour S, Wong J, et al. NF-kappaB restricts inflammasome activation via elimination of damaged mitochondria. Cell. 2016;164(5):896\u2013910.","journal-title":"Cell"},{"issue":"3","key":"4627_CR76","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011;12(3):222\u201330.","journal-title":"Nat Immunol"},{"issue":"2","key":"4627_CR77","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10(2):128.","journal-title":"Cell Death Dis"},{"key":"4627_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108719","volume":"108","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Huang Y, Chen M, Yang Y, Li X, Zhang W. Mitochondrial DNA in NLRP3 inflammasome activation. Int Immunopharmacol. 2022;108: 108719.","journal-title":"Int Immunopharmacol"},{"issue":"6403","key":"4627_CR79","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1126\/science.aat1022","volume":"361","author":"M Du","year":"2018","unstructured":"Du M, Chen ZJ. DNA-induced liquid phase condensation of cGAS activates innate immune signaling. Science. 2018;361(6403):704\u20139.","journal-title":"Science"},{"issue":"8","key":"4627_CR80","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.tem.2022.04.009","volume":"33","author":"V Vella","year":"2022","unstructured":"Vella V, De Francesco EM, Bonavita E, Lappano R, Belfiore A. IFN-I signaling in cancer: the connection with dysregulated Insulin\/IGF axis. Trends Endocrinol Metab. 2022;33(8):569\u201386.","journal-title":"Trends Endocrinol Metab"},{"issue":"36","key":"4627_CR81","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1074\/jbc.M117.804005","volume":"292","author":"L Yuan","year":"2017","unstructured":"Yuan L, Mao Y, Luo W, Wu W, Xu H, Wang XL, et al. Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism. J Biol Chem. 2017;292(36):15002\u201315.","journal-title":"J Biol Chem"},{"issue":"1","key":"4627_CR82","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s42003-020-0986-1","volume":"3","author":"J Bai","year":"2020","unstructured":"Bai J, Cervantes C, He S, He J, Plasko GR, Wen J, et al. Mitochondrial stress-activated cGAS-STING pathway inhibits thermogenic program and contributes to overnutrition-induced obesity in mice. Commun Biol. 2020;3(1):257.","journal-title":"Commun Biol"},{"key":"4627_CR83","doi-asserted-by":"crossref","unstructured":"Zhang Q, Wei J, Liu Z, Huang X, Sun M, Lai W, et al. Corrigendum to \u201cSTING signaling sensing of DRP1-dependent mtDNA release in kupffer cells contributes to lipopolysaccharide-induced liver injury in mice\u201d [Redox Biol. 54 (2022) 102367\/PMID:35724543]. Redox Biol. 2023;62:102664.","DOI":"10.1016\/j.redox.2023.102664"},{"issue":"7799","key":"4627_CR84","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","volume":"579","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579(7799):415\u201320.","journal-title":"Nature"},{"issue":"2","key":"4627_CR85","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jhep.2020.04.001","volume":"73","author":"J Gautheron","year":"2020","unstructured":"Gautheron J, Gores GJ, Rodrigues CMP. Lytic cell death in metabolic liver disease. J Hepatol. 2020;73(2):394\u2013408.","journal-title":"J Hepatol"},{"issue":"3","key":"4627_CR86","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI83885","volume":"126","author":"I Garcia-Martinez","year":"2016","unstructured":"Garcia-Martinez I, Santoro N, Chen Y, Hoque R, Ouyang X, Caprio S, et al. Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest. 2016;126(3):859\u201364.","journal-title":"J Clin Invest"},{"issue":"3","key":"4627_CR87","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147(3):577-94 e1.","journal-title":"Gastroenterology"},{"issue":"16","key":"4627_CR88","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1042\/CS20160838","volume":"131","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, Haczeyni F, Yeh MM, Haigh WG, Ioannou GN, Barn V, et al. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival. Clin Sci (Lond). 2017;131(16):2145\u201359.","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"4627_CR89","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","volume":"47","author":"CA Rivera","year":"2007","unstructured":"Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol. 2007;47(4):571\u20139.","journal-title":"J Hepatol"},{"issue":"Suppl 6","key":"4627_CR90","doi-asserted-by":"publisher","first-page":"s15","DOI":"10.7861\/clinmedicine.13-6-s15","volume":"13","author":"WK Syn","year":"2013","unstructured":"Syn WK. Repair-associated inflammation in nonalcoholic fatty liver disease. Clin Med (Lond). 2013;13(Suppl 6):s15\u20139.","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"4627_CR91","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","volume":"79","author":"F Tacke","year":"2023","unstructured":"Tacke F, Puengel T, Loomba R, Friedman SL. An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH. J Hepatol. 2023;79(2):552\u201366.","journal-title":"J Hepatol"},{"issue":"3","key":"4627_CR92","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1055\/s-0040-1708540","volume":"40","author":"J Knorr","year":"2020","unstructured":"Knorr J, Wree A, Tacke F, Feldstein AE. The NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis. 2020;40(3):298\u2013306.","journal-title":"Semin Liver Dis"},{"key":"4627_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.867940","volume":"13","author":"JK Carter","year":"2022","unstructured":"Carter JK, Friedman SL. Hepatic stellate cell-immune interactions in NASH. Front Endocrinol (Lausanne). 2022;13: 867940.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"4627_CR94","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1172\/JCI121842","volume":"129","author":"Y Yu","year":"2019","unstructured":"Yu Y, Liu Y, An W, Song J, Zhang Y, Zhao X. STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. J Clin Invest. 2019;129(2):546\u201355.","journal-title":"J Clin Invest"},{"issue":"1","key":"4627_CR95","doi-asserted-by":"publisher","first-page":"2166763","DOI":"10.1080\/15384047.2023.2166763","volume":"24","author":"H Luo","year":"2023","unstructured":"Luo H, Sun Y, Wang L, Liu H, Zhao R, Song M, et al. Targeting endoplasmic reticulum associated degradation pathway combined with radiotherapy enhances the immunogenicity of esophageal cancer cells. Cancer Biol Ther. 2023;24(1):2166763.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"4627_CR96","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","volume":"155","author":"X Luo","year":"2018","unstructured":"Luo X, Li H, Ma L, Zhou J, Guo X, Woo SL, et al. Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology. 2018;155(6):1971-84 e4.","journal-title":"Gastroenterology"},{"issue":"7","key":"4627_CR97","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.cell.2015.11.045","volume":"163","author":"AG York","year":"2015","unstructured":"York AG, Williams KJ, Argus JP, Zhou QD, Brar G, Vergnes L, et al. Limiting cholesterol biosynthetic flux spontaneously engages type I IFN signaling. Cell. 2015;163(7):1716\u201329.","journal-title":"Cell"},{"issue":"5","key":"4627_CR98","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17(5):306\u201321.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4627_CR99","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, et al. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol. 2021;74(1):156\u201367.","journal-title":"J Hepatol"},{"issue":"2","key":"4627_CR100","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/hep.30252","volume":"69","author":"ME Inzaugarat","year":"2019","unstructured":"Inzaugarat ME, Johnson CD, Holtmann TM, McGeough MD, Trautwein C, Papouchado BG, et al. NLR family pyrin domain-containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice. Hepatology. 2019;69(2):845\u201359.","journal-title":"Hepatology"},{"issue":"6","key":"4627_CR101","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jhep.2016.01.035","volume":"64","author":"S Bala","year":"2016","unstructured":"Bala S, Csak T, Saha B, Zatsiorsky J, Kodys K, Catalano D, et al. The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis. J Hepatol. 2016;64(6):1378\u201387.","journal-title":"J Hepatol"},{"issue":"4","key":"4627_CR102","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep4.1479","volume":"4","author":"G Parthasarathy","year":"2020","unstructured":"Parthasarathy G, Revelo X, Malhi H. Pathogenesis of nonalcoholic steatohepatitis: an overview. Hepatol Commun. 2020;4(4):478\u201392.","journal-title":"Hepatol Commun"},{"key":"4627_CR103","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12967-015-0552-7","volume":"13","author":"M Ganz","year":"2015","unstructured":"Ganz M, Bukong TN, Csak T, Saha B, Park JK, Ambade A, et al. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. J Transl Med. 2015;13:193.","journal-title":"J Transl Med"},{"issue":"4","key":"4627_CR104","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cphy.c120035","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3(4):1473\u201392.","journal-title":"Compr Physiol"},{"issue":"3","key":"4627_CR105","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/JCI30542","volume":"117","author":"JP Iredale","year":"2007","unstructured":"Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 2007;117(3):539\u201348.","journal-title":"J Clin Invest"},{"issue":"7","key":"4627_CR106","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"4627_CR107","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/hep.25559","volume":"55","author":"CD Guy","year":"2012","unstructured":"Guy CD, Suzuki A, Zdanowicz M, Abdelmalek MF, Burchette J, Unalp A, et al. Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology. 2012;55(6):1711\u201321.","journal-title":"Hepatology"},{"issue":"4","key":"4627_CR108","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","volume":"142","author":"V Hernandez-Gea","year":"2012","unstructured":"Hernandez-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, Yue Z, et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology. 2012;142(4):938\u201346.","journal-title":"Gastroenterology"},{"issue":"15","key":"4627_CR109","doi-asserted-by":"publisher","first-page":"8298","DOI":"10.3390\/ijms22158298","volume":"22","author":"HC Monroy-Ramirez","year":"2021","unstructured":"Monroy-Ramirez HC, Galicia-Moreno M, Sandoval-Rodriguez A, Meza-Rios A, Santos A, Armendariz-Borunda J. PPARs as metabolic sensors and therapeutic targets in liver diseases. Int J Mol Sci. 2021;22(15):8298.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4627_CR110","first-page":"135","volume":"80","author":"H Partsch","year":"1986","unstructured":"Partsch H. Hyperemic hypoxia in venous ulcer. Z Arztl Fortbild (Jena). 1986;80(3):135\u20137.","journal-title":"Z Arztl Fortbild (Jena)"},{"issue":"1","key":"4627_CR111","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1017\/S0954422418000239","volume":"32","author":"S Campisano","year":"2019","unstructured":"Campisano S, La Colla A, Echarte SM, Chisari AN. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. Nutr Res Rev. 2019;32(1):128\u201345.","journal-title":"Nutr Res Rev"},{"issue":"6","key":"4627_CR112","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/hep.23599","volume":"51","author":"WK Syn","year":"2010","unstructured":"Syn WK, Oo YH, Pereira TA, Karaca GF, Jung Y, Omenetti A, et al. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology. 2010;51(6):1998\u20132007.","journal-title":"Hepatology"},{"issue":"9","key":"4627_CR113","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","volume":"61","author":"WK Syn","year":"2012","unstructured":"Syn WK, Agboola KM, Swiderska M, Michelotti GA, Liaskou E, Pang H, et al. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut. 2012;61(9):1323\u20139.","journal-title":"Gut"},{"issue":"6","key":"4627_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2022.12724","volume":"25","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wu Y, Shen W, Wang B, Yuan X. Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review). Mol Med Rep. 2022;25(6):1\u20137.","journal-title":"Mol Med Rep"},{"issue":"7854","key":"4627_CR115","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","volume":"592","author":"M Dudek","year":"2021","unstructured":"Dudek M, Pfister D, Donakonda S, Filpe P, Schneider A, Laschinger M, et al. Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH. Nature. 2021;592(7854):444\u20139.","journal-title":"Nature"},{"issue":"2","key":"4627_CR116","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/hep4.1807","volume":"6","author":"J Dywicki","year":"2022","unstructured":"Dywicki J, Buitrago-Molina LE, Noyan F, Davalos-Misslitz AC, Hupa-Breier KL, Lieber M, et al. The detrimental role of regulatory T cells in nonalcoholic steatohepatitis. Hepatol Commun. 2022;6(2):320\u201333.","journal-title":"Hepatol Commun"},{"issue":"2","key":"4627_CR117","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s12072-012-9345-8","volume":"7","author":"T Miyake","year":"2013","unstructured":"Miyake T, Abe M, Tokumoto Y, Hirooka M, Furukawa S, Kumagi T, et al. B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease. Hepatol Int. 2013;7(2):539\u201347.","journal-title":"Hepatol Int"},{"issue":"11","key":"4627_CR118","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.drudis.2017.06.007","volume":"22","author":"HH Hansen","year":"2017","unstructured":"Hansen HH, Feigh M, Veidal SS, Rigbolt KT, Vrang N, Fosgerau K. Mouse models of nonalcoholic steatohepatitis in preclinical drug development. Drug Discov Today. 2017;22(11):1707\u201318.","journal-title":"Drug Discov Today"},{"key":"4627_CR119","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12944-016-0194-7","volume":"15","author":"J Liu","year":"2016","unstructured":"Liu J, Han L, Zhu L, Yu Y. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats. Lipids Health Dis. 2016;15:27.","journal-title":"Lipids Health Dis"},{"issue":"11","key":"4627_CR120","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.jdiacomp.2017.07.014","volume":"31","author":"N Samala","year":"2017","unstructured":"Samala N, Tersey SA, Chalasani N, Anderson RM, Mirmira RG. Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase. J Diabetes Complications. 2017;31(11):1630\u20137.","journal-title":"J Diabetes Complications"},{"issue":"4","key":"4627_CR121","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","volume":"67","author":"M Romero-Gomez","year":"2017","unstructured":"Romero-Gomez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017;67(4):829\u201346.","journal-title":"J Hepatol"},{"issue":"1","key":"4627_CR122","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","volume":"27","author":"VT Samuel","year":"2018","unstructured":"Samuel VT, Shulman GI. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab. 2018;27(1):22\u201341.","journal-title":"Cell Metab"},{"issue":"5","key":"4627_CR123","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/apt.14210","volume":"46","author":"SA Townsend","year":"2017","unstructured":"Townsend SA, Newsome PN. Review article: new treatments in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2017;46(5):494\u2013507.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"4627_CR124","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/nu9101158","volume":"9","author":"P Silva Figueiredo","year":"2017","unstructured":"Silva Figueiredo P, Carla Inada A, Marcelino G, Maiara Lopes Cardozo C, de Cassia Freitas K, de Cassia Avellaneda Guimaraes R, et al. Fatty acids consumption: the role metabolic aspects involved in obesity and its associated disorders. Nutrients. 2017;9(10):1158.","journal-title":"Nutrients"},{"key":"4627_CR125","first-page":"221","volume":"7","author":"A Berlanga","year":"2014","unstructured":"Berlanga A, Guiu-Jurado E, Porras JA, Auguet T. Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol. 2014;7:221\u201339.","journal-title":"Clin Exp Gastroenterol"},{"issue":"2","key":"4627_CR126","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2741\/4892","volume":"26","author":"S Raza","year":"2021","unstructured":"Raza S, Rajak S, Upadhyay A, Tewari A, Anthony SR. Current treatment paradigms and emerging therapies for NAFLD\/NASH. Front Biosci (Landmark Ed). 2021;26(2):206\u201337.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"3","key":"4627_CR127","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida Y, Yoneda M. Current and future pharmacological therapies for NAFLD\/NASH. J Gastroenterol. 2018;53(3):362\u201376.","journal-title":"J Gastroenterol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04627-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04627-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04627-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T13:03:20Z","timestamp":1698325400000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04627-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4627"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04627-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"757"}}